A BILL 
To amend the Controlled Substances Act to require physi-
cians and other prescribers of controlled substances to 
complete training on treating and managing patients 
with opioid and other substance use disorders, and for 
other purposes. 
Be it enacted by the Senate and House of Representa-
1
tives of the United States of America in Congress assembled, 
2
04:47 May 19, 2021
H2067
2 
•HR 2067 IH
SECTION 1. SHORT TITLE. 
1
This Act may be cited as the ‘‘Medication Access and 
2
Training Expansion Act of 2021’’ or the ‘‘MATE Act of 
3
2021’’. 
4
SEC. 2. REQUIRING PRESCRIBERS OF CONTROLLED SUB-
5
STANCES 
TO 
COMPLETE 
TRAINING 
ON 
6
TREATING AND MANAGING PATIENTS WITH 
7
OPIOID AND OTHER SUBSTANCE USE DIS-
8
ORDERS. 
9
Section 303 of the Controlled Substances Act (21 
10
U.S.C. 823) is amended by adding at the end the fol-
11
lowing: 
12
‘‘(l) REQUIRED TRAINING
FOR PRESCRIBERS
ON 
13
TREATING AND MANAGING PATIENTS WITH OPIOID AND 
14
OTHER SUBSTANCE USE DISORDERS.— 
15
‘‘(1) 
APPLICABILITY.—This 
subsection 
ap-
16
plies— 
17
‘‘(A) with respect to any practitioner who 
18
is licensed under State law to prescribe con-
19
trolled substances and is not a veterinarian or 
20
a dentist; and 
21
‘‘(B) beginning with the first registration 
22
or renewal of registration by the practitioner 
23
under this section occurring 180 or more days 
24
after the date of enactment of the Medication 
25
Access and Training Expansion Act of 2021. 
26
04:47 May 19, 2021
H2067
3 
•HR 2067 IH
‘‘(2) TRAINING REQUIRED.—As a condition on 
1
registration under this section to dispense controlled 
2
substances in schedule II, III, IV, or V, the Attorney 
3
General shall require any practitioner described in 
4
paragraph (1)(A) to meet the following: 
5
‘‘(A) If the practitioner is a physician, the 
6
practitioner must meet one or more of the fol-
7
lowing conditions: 
8
‘‘(i) The physician holds a board cer-
9
tification in addiction psychiatry or addic-
10
tion medicine from the American Board of 
11
Medical Specialties. 
12
‘‘(ii) The physician holds a board cer-
13
tification from the American Board of Ad-
14
diction Medicine. 
15
‘‘(iii) The physician holds a board cer-
16
tification in addiction medicine from the 
17
American Osteopathic Association. 
18
‘‘(iv) The physician has, with respect 
19
to the treatment and management of pa-
20
tients with opioid or other substance use 
21
disorders, completed not less than 8 hours 
22
of training (through classroom situations, 
23
seminars at professional society meetings, 
24
04:47 May 19, 2021
H2067
4 
•HR 2067 IH
electronic communications, or otherwise) 
1
that is provided by— 
2
‘‘(I) the American Society of Ad-
3
diction Medicine, the American Acad-
4
emy of Addiction Psychiatry, the 
5
American Medical Association, the 
6
American Osteopathic Association, the 
7
American Psychiatric Association, or 
8
any other organization accredited by 
9
the Accreditation Council for Con-
10
tinuing Medical Education (commonly 
11
known as the ‘ACCME’); 
12
‘‘(II) any organization accredited 
13
by a State medical society accreditor 
14
recognized by the ACCME; or 
15
‘‘(III) any organization accred-
16
ited by the American Osteopathic As-
17
sociation to provide continuing med-
18
ical education. 
19
‘‘(v) The physician graduated in good 
20
standing from an accredited school of 
21
allopathic medicine or osteopathic medicine 
22
in the United States during the 5-year pe-
23
riod immediately preceding the date on 
24
which the physician first registers or re-
25
04:47 May 19, 2021
H2067
5 
•HR 2067 IH
news under this section and has success-
1
fully completed a comprehensive allopathic 
2
or osteopathic medicine curriculum or ac-
3
credited medical residency that included 
4
not less than 8 hours of training on treat-
5
ing and managing patients with opioid and 
6
other substance use disorders, including 
7
the appropriate clinical use of all drugs ap-
8
proved by the Food and Drug Administra-
9
tion for the treatment of a substance use 
10
disorder. 
11
‘‘(B) If the practitioner is not a physician, 
12
the practitioner must meet one or more of the 
13
following conditions: 
14
‘‘(i) Completed not fewer than 8 hours 
15
of training with respect to the treatment 
16
and management of patients with opioid or 
17
other substance use disorders (through 
18
classroom situations, seminars at profes-
19
sional society meetings, electronic commu-
20
nications, or otherwise) provided by the 
21
American Society of Addiction Medicine, 
22
the American Academy of Addiction Psy-
23
chiatry, the American Medical Association, 
24
the American Osteopathic Association, the 
25
04:47 May 19, 2021
H2067
6 
•HR 2067 IH
American Nurses Credentialing Center, the 
1
American 
Psychiatric 
Association, 
the 
2
American Association of Nurse Practi-
3
tioners, the American Academy of Physi-
4
cian Assistants, or any other organization 
5
that the Secretary determines is appro-
6
priate for purposes of this clause. 
7
‘‘(ii) Graduated in good standing from 
8
an accredited physician assistant school or 
9
accredited school of advanced practice 
10
nursing in the United States during the 5- 
11
year period immediately preceding the date 
12
on which the practitioner first registers or 
13
renews under this section and has success-
14
fully completed a comprehensive physician 
15
assistant or advanced practice nursing cur-
16
riculum that included not less than 8 hours 
17
of training on treating and managing pa-
18
tients with opioid and other substance use 
19
disorders, including the appropriate clinical 
20
use of all drugs approved by the Food and 
21
Drug Administration for the treatment of 
22
a substance use disorder. 
23
‘‘(3) ONE-TIME TRAINING.—The Attorney Gen-
24
eral shall not require any practitioner to complete 
25
04:47 May 19, 2021
H2067
7 
•HR 2067 IH
the training described in clause (iv) or (v) of para-
1
graph (2)(A) or clause (i) or (ii) of paragraph 
2
(2)(B) more than once. 
3
‘‘(4) RULE
OF
CONSTRUCTION.—Nothing in 
4
this subsection shall be construed to prevent a prac-
5
titioner from using the same training both for pur-
6
poses of satisfying the registration requirement of 
7
this subsection and for other purposes, such as satis-
8
fying State licensing requirements.’’. 
9
SEC. 3. PRACTITIONER EDUCATION GRANT PROGRAM. 
10
Title V of the Public Health Service Act is amended 
11
by inserting after section 509 of such Act (42 U.S.C. 
12
290bb–2) the following: 
13
‘‘SEC. 510. PRACTITIONER EDUCATION GRANT PROGRAM. 
14
‘‘(a) IN GENERAL.—The Secretary shall carry out a 
15
program to award grants to eligible entities to expand the 
16
integration of substance use disorder education into the 
17
standard curriculum of relevant health care and health 
18
services education programs, thereby expanding the num-
19
ber of practitioners who deliver high-quality, evidence- 
20
based substance use disorder treatment. 
21
‘‘(b) ELIGIBLE ENTITIES.—To be eligible to receive 
22
a grant under this section, an entity shall be— 
23
‘‘(1) a private nonprofit or public professional 
24
association representing health care professionals in 
25
04:47 May 19, 2021
H2067
8 
•HR 2067 IH
the field of medicine, physician assistants, nursing, 
1
social work, psychology, marriage and family ther-
2
apy, or health services administration; or 
3
‘‘(2) a private nonprofit or public entity that is 
4
a university, college, or other professional school. 
5
‘‘(c) AUTHORIZATION
OF
APPROPRIATIONS.—To 
6
carry out this section, there is authorized to be appro-
7
priated such sums as may be necessary for each of fiscal 
8
years 2022 through 2027.’’. 
9
Æ 
04:47 May 19, 2021
H2067
